101 related articles for article (PubMed ID: 15517556)
1. Economic evaluation of ultrasound screening options for structural fetal malformations.
Vanara F; Bergeretti F; Gaglioti P; Todros T
Ultrasound Obstet Gynecol; 2004 Nov; 24(6):633-9. PubMed ID: 15517556
[TBL] [Abstract][Full Text] [Related]
2. Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities.
Ritchie K; Bradbury I; Slattery J; Wright D; Iqbal K; Penney G
BJOG; 2005 Jul; 112(7):866-74. PubMed ID: 15957985
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
Kott B; Dubinsky TJ
J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
[TBL] [Abstract][Full Text] [Related]
4. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of prenatal carrier screening for fragile X syndrome.
Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
7. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
8. Fetal malformations diagnosed antenatally 1: General principles.
Sprigg A
Br J Hosp Med; 1995 Oct 18-31; 54(8):387-90. PubMed ID: 8535590
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasound screening in pregnancy: evidence and maternity care reality].
Jahn A
Z Arztl Fortbild Qualitatssich; 2002 Dec; 96(10):649-54. PubMed ID: 12611051
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of tandem mass spectrometry screening in California.
Feuchtbaum L; Cunningham G
Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
12. [[Prenatal ultrasonography in Switzerland--a repersentative national survey] ].
Wegmann B; Huch R; Huch A; Zimmermann R
Ultraschall Med; 2000 Oct; 21(5):210-7. PubMed ID: 11126601
[TBL] [Abstract][Full Text] [Related]
13. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.
Musci TJ; Caughey AB
Am J Obstet Gynecol; 2005 Jun; 192(6):1905-12; discussion 1912-5. PubMed ID: 15970847
[TBL] [Abstract][Full Text] [Related]
15. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
16. Choosing options for ultrasound screening in pregnancy and comparing cost effectiveness: a decision analysis approach.
Roberts T; Mugford M; Piercy J
Br J Obstet Gynaecol; 1998 Sep; 105(9):960-70. PubMed ID: 9763046
[TBL] [Abstract][Full Text] [Related]
17. Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination.
Peller AJ; Westgate MN; Holmes LB
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):957-64. PubMed ID: 15516385
[TBL] [Abstract][Full Text] [Related]
18. The Routine Antenatal Diagnostic Imaging with Ultrasound Study: another perspective.
DeVore GR
Obstet Gynecol; 1994 Oct; 84(4):622-6. PubMed ID: 8090403
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
Demyttenaere K; Hemels ME; Hudry J; Annemans L
Clin Ther; 2005 Jan; 27(1):111-24. PubMed ID: 15763612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
